The Asia Pacific Veterinary PoC Diagnostics Market was valued at $256.9 Million in 2026 and projected to reach to $398.4 Million by 2031, representing a compound annual growth rate of 9.2%. The Asia Pacific veterinary PoC diagnostics market is positioned for sustained growth, expanding from USD 256.9 million in 2026 to USD 398.4 million by 2031.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Asia Pacific's veterinary PoC diagnostics market grows at 9.2% CAGR, significantly outpacing the global average of 7.7%, driven by rapid urbanization and increasing pet healthcare spending across the region.
China dominates Asia Pacific with USD 144.1 million in market size, reflecting surging pet ownership and livestock disease management initiatives across the world's most populous nation.
Rapid growth in companion animal ownership across Japan, South Korea, and Australia is fueling demand for accessible, rapid diagnostic solutions in veterinary clinics and animal hospitals.
Increasing government focus on livestock health monitoring and biosecurity in India and Southeast Asia is accelerating adoption of point-of-care diagnostic technologies for disease prevention.
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | MOLECULAR DIAGNOSTICS (Technology) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 7.7% from 2026 to 2031 |
| Largest Segment | CONSUMABLES (Product) |
| Market Size Base Year (Billions) | ~USD 1.19 (2026) |
| Revenue Forecast (Billions) | ~USD 1.72 (2031) |
| Segments Covered | Product, Animal Type, Type, Technology, Livestock Type, Molecular Diagnostics |
6 segment dimensions are covered across the global market.
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| GENERAL ELECTRIC | United States | Public Company | Commercial Engines & Services,Defense & Propulsion Technologies,Additive and Advanced Components, |
| IDEXX LABORATORIES, INC. | United States | Public Company | Companion Animal Group (in-clinic analyzers, reference labs, software, services),Livestock, Poultry and Dairy Diagnostics,Water Quality Products, |
| THERMO FISHER SCIENTIFIC INC. | United States | Public Company | Life Sciences Solutions,Analytical Instruments,Specialty Diagnostics, |
| BIONOTE | South Korea | Public Company | Veterinary fluorescence immunoassay and molecular diagnostics,Veterinary clinical biochemistry systems and reagents,Veterinary rapid immunoassay and ELISA kits, |
| BIOMéRIEUX | France | Public Company | Microbiology ID/AST systems (VITEK 2, VITEK MS, VITEK REVEAL, API, ETEST),Syndromic and molecular diagnostics (BIOFIRE, BIOFIRE SPOTFIRE, ARGENE, EMAG/NUCLISENS),Sepsis, immunoassay, and specialty markers (VIDAS, Hybiome CLIA), |
| VIRBAC | France | Public Company | Companion animal parasiticides (e.g., Prevexto),Companion animal chronic-care nutrition (e.g., Vikaly, petfood),Behavior and stress management (Zenidog/Zenifel), |
General Electric is a publicly traded United States company founded in 1892 that operates with 57,000 employees.
IDEXX Laboratories, Inc. is a publicly traded United States company founded in 1983 with 11,000 employees.
Thermo Fisher Scientific Inc. is a publicly traded United States company founded in 1956 with 125,000 employees.
BioNote is a publicly traded South Korean company founded in 2003 with 298 employees.
bioMérieux is a publicly traded French company founded in 1963 with 14,894 employees.
Virbac is a publicly traded French company founded in 1968 with 6,442 employees.
| Country | 2025 size (native) |
|---|---|
| China | USD 144.1 Million |
| Japan | USD 92.8 Million |
| India | USD 79.2 Million |
| Australia | USD 18.8 Million |
| South Korea | USD 26.1 Million |
| New Zealand | USD 10 Million |
| Thailand | USD 11.8 Million |
| Rest Of Asia Pacific | USD 15.5 Million |
Asia Pacific's veterinary PoC diagnostics market was valued at USD 256.9 million in 2026 and is projected to grow to USD 398.4 million by 2031.
Asia Pacific's veterinary PoC diagnostics market is expected to grow at a compound annual growth rate (CAGR) of 9.2% from 2026 to 2031.
Key markets within Asia Pacific include China, India, Japan, and Southeast Asian nations, which are investing in veterinary diagnostic infrastructure and disease prevention capabilities.
Rising pet ownership, increasing livestock disease surveillance, expanding middle-class populations, improved healthcare infrastructure, and regulatory support for disease prevention are primary growth drivers in Asia Pacific.
Asia Pacific's 9.2% CAGR significantly outpaces the global average of 7.7%, reflecting the region's accelerating demand for rapid, accessible diagnostic solutions in veterinary care.
This research study extensively utilized both primary and secondary sources. It involved analyzing various factors influencing the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and strategies employed by key players.
This research study utilized a variety of comprehensive secondary sources, including directories; databases such as Bloomberg Business, Factiva, and Dun & Bradstreet; and white papers, annual reports, company house documents, investor presentations, and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the veterinary PoC diagnostics market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments pertaining to both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.
In the primary research process, we interviewed a range of sources from both the supply and demand sides to gather qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the veterinary PoC diagnostics market. Primary sources from the demand side include small and large animal veterinarians, veterinary clinic and hospital owners, managers of livestock farms and dairy operations, directors of veterinary diagnostic laboratories, officials from government animal health and regulatory agencies, and procurement and purchasing teams from veterinary clinics, hospitals, and farm operations.
A breakdown of the primary respondents is provided below:
Breakdown Of Primary Interviews: Supply-Side Participants, By Company Type, Designation, And Region
Note: C-level executives include CEOs, COOs, CTOs, and VPs.
Other designations include sales, marketing, and product managers.
Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
The total size of the veterinary PoC diagnostics market was determined after data triangulation from three approaches, as mentioned below. After each approach, the weighted average of the three approaches was taken based on the level of assumptions used in each approach.

After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed wherever applicable to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
The veterinary PoC diagnostics market comprises products and technologies used for rapid, on-site diagnosis of diseases and health conditions in animals, enabling immediate clinical decision-making without reliance on centralized laboratories. The market includes consumables (such as test kits, cartridges, strips, and reagents) and instruments (including portable analyzers and handheld diagnostic devices) and covers key technologies such as molecular diagnostics (PCR-based, isothermal amplification, and CRISPR-based methods), immunodiagnostics, and other techniques, including clinical chemistry and hematology. It serves both companion animals (dogs, cats, horses, and others) and livestock (cattle, pigs, poultry, and others), with applications spanning infectious disease detection, routine health monitoring, and preventive care across veterinary clinics, farms, and field settings.
1. Micromarkets are defined as the further segments and subsegments of the veterinary PoC diagnostics market included in the report.
2. Core competencies of companies are captured in terms of the key developments and strategies adopted by them to sustain their market positions.
With the given market data, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:
Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the veterinary PoC diagnostics market
Full forecast, segment splits, and company analysis for all Veterinary PoC Diagnostics Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report